Literature DB >> 36209340

Prevalence and Retrospective Insight on Tuberculosis in Human Patients in Cross River State, Nigeria; One Health Approach to its Control.

Peter M Bikom1, Innocent O Nwankwo2, John A Nwanta3.   

Abstract

Tuberculosis (TB) is a major zoonotic disease of public health importance worldwide. Its burden is more in developing countries due to inadequate surveillance, co-infection with HIV/AIDS and poor social amenities; hence consumption of unpasteurized milk, contaminated meat and inhalation of infected droplets from animals or patients with active TB are the major risk practices. A survey was conducted on TB prevalence from 2013 to 2014 while patients records from TB and Leprosy units of hospitals in the three Agricultural zones (Ogoja, Ikom and Calabar) of Cross River State, Nigeria were assessed from 2000 to 2010. Out of 1,170 sampled patients, 8 (0.7%) were positive, of which 6 and 2 isolates were identified as M. tuberculosis and M. bovis, respectively. Out of 52,558 studied patients files, 235 (0.4%) were positive with varied annual prevalence; the highest (1.0%) and lowest (0.2%) in 2009 and 2011, respectively. The prevalence was higher in dry (0.9% and 0.5%) than the rainy season (0.5% and 0.4%), in females (0.9% and 0.5%) than the males (0.4% and 0.4%) in the survey and retrospective studies, respectively. The age distribution of TB among the patients were; (0% and 0.3%), (0.4% and 0.4%), (0.7% and 0.4%) and (1.5% and 0.7%) for those (≤ 18), (19-40), (41-60) and (> 60) yrs old in the survey and retrospective study, respectively. TB is prevalent in human patients in Cross River State hence, the need for sustainable campaign, continuous surveillance and private/ public health partnership in accurate and early diagnosis, treatment and one health approach to its control.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Year:  2022        PMID: 36209340     DOI: 10.1007/s00284-022-03046-6

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.343


  15 in total

1.  Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria.

Authors:  Simeon Cadmus; Si Palmer; Melissa Okker; James Dale; Karen Gover; Noel Smith; Keith Jahans; R Glyn Hewinson; Stephen V Gordon
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Epidemiology and endemicity of pulmonary tuberculosis (PTB) in Southeastern Nigeria.

Authors:  Alfred Young Itah; Silas Michael Udofia
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-03       Impact factor: 0.267

Review 3.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

4.  An exploration of patient perceptions of adherence to tuberculosis treatment in Tanzania.

Authors:  Jossy van den Boogaard; Elisabeth Msoka; Mike Homfray; Gibson S Kibiki; Jeannette J H M Heldens; Albert J A Felling; Rob E Aarnoutse
Journal:  Qual Health Res       Date:  2012-03-05

5.  Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.

Authors:  V Mauch; F Bonsu; M Gyapong; E Awini; P Suarez; B Marcelino; R E Melgen; K Lönnroth; N V Nhung; N B Hoa; E Klinkenberg
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

6.  Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.

Authors:  Said Abbadi; G El Hadidy; N Gomaa; Robert Cooksey
Journal:  Int J Infect Dis       Date:  2008-10-05       Impact factor: 3.623

Review 7.  Zoonotic Mycobacterium bovis-induced tuberculosis in humans.

Authors:  Borna Müller; Salome Dürr; Silvia Alonso; Jan Hattendorf; Cláudio J M Laisse; Sven D C Parsons; Paul D van Helden; Jakob Zinsstag
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

8.  PREVALENCE OF TUBERCULOSIS, DRUG-RESISTANT TUBERCULOSIS AND HIV/TB CO-INFECTION IN ENUGU, NIGERIA.

Authors:  Kennethe Okonkeo Ugwu; Martin Chinonye Agbo; Ifeoma Maureen Ezeonu
Journal:  Afr J Infect Dis       Date:  2021-03-18

9.  Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study.

Authors:  Takele Tadesse; Meaza Demissie; Yemane Berhane; Yigzaw Kebede; Markos Abebe
Journal:  BMC Public Health       Date:  2013-05-01       Impact factor: 3.295

10.  Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Authors:  Gambo Aliyu; Samer S El-Kamary; Alash'le Abimiku; Nicholas Ezati; Iwakun Mosunmola; Laura Hungerford; Clayton Brown; Kathleen J Tracy; Joshua Obasanya; William Blattner
Journal:  Tuberc Res Treat       Date:  2013-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.